The aim of this study was to assess serum FGF21 concentration in patients with gestational diabetes, individuals with type 2 diabetes, and the respective control groups, as well as to determine the correlation between the studied protein and selected biochemical parameters (glucose, insulin, HbA1c, total cholesterol, HDL, and TG). This evidence concerns the gene INS and type 2 diabetes mellitus.